Literature DB >> 18362251

The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy.

Anand Khurana1, Luciana McLean, Sheree Atkinson, Charles J Foulks.   

Abstract

BACKGROUND: Oral sodium phosphate solution (OSPS) preparations are preferred cleansing agents for colonoscopy because of ease of use and excellent preparation quality. Besides causing acute renal failure in some patients, the high phosphorus content can potentially cause chronic kidney damage to patients undergoing colonoscopy.
METHODS: We carried out a retrospective study on patients with creatinine levels in the normal range who had undergone colonoscopy or flexible sigmoidoscopy using OSPS preparation from January 1998 to February 2005 and followed them for 1 year to determine its effects on their renal function. A control group of patients with similar comorbidities during this period were chosen to assess age-related decline in renal function in this population.
RESULTS: A total of 286 patients were selected in the study group, and 125 patients were selected in the control group. Both groups had similar baseline characteristics. The baseline glomerular filtration rate (GFR) in the study group was 79 mL/min/1.73 m(2), which declined to 73 mL/min/1.73 m(2) at 6 months after exposure to OSPS preparation. This finding was significantly different from the control group, in whom the baseline GFR was 76 mL/min/1.73 m(2) and remained stable at 6 months. Linear regression analysis showed that use of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers and the presence of diabetes were significant determinants of the fall in GFR after use of OSPS preparation.
CONCLUSIONS: Oral sodium phosphate solution preparation is associated with decline in GFR in elderly patients with creatinine levels in the normal range. Its routine use for elective and screening procedures should be discouraged in the elderly population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362251     DOI: 10.1001/archinte.168.6.593

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  20 in total

1.  Colonoscopy: Oral sodium phosphate may worsen kidney dysfunction.

Authors:  Anand Khurana
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

2.  Clinical pearls in gastroenterology.

Authors:  Amy S Oxentenko; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

3.  Colonoscopy preparation-induced disorders in renal function and electrolytes.

Authors:  Matilda Florentin; George Liamis; Moses S Elisaf
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

4.  Comparison of concurrent complications of CKD by 2 risk categorization systems.

Authors:  Lesley A Inker; Marcello Tonelli; Brenda R Hemmelgarn; Emily B Levitan; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2011-11-23       Impact factor: 8.860

Review 5.  The safety of osmotically acting cathartics in colonic cleansing.

Authors:  Caroline Nyberg; Jakob Hendel; Ole H Nielsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-24       Impact factor: 46.802

6.  Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance.

Authors:  Lesley A Stevens; Gautham Viswanathan; Daniel E Weiner
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

7.  Does 2 L Polyethylene Glycol Plus Ascorbic Acid Increase the Risk of Renal Impairment Compared to 4 L Polyethylene Glycol?

Authors:  Sang Pyo Lee; Eugene Park; Han Viet Kim; In-Kyung Sung; Jeong Hwan Kim; Sun-Young Lee; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2016-09-13       Impact factor: 3.199

8.  A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status.

Authors:  M A Korsten; A M Spungen; A R Rosman; H R Ancha; J B Post; S Shaw; K K Hunt; R Williams; W A Bauman
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 9.  Strategies for the preservation of residual renal function in pediatric dialysis patients.

Authors:  Melissa A Cadnapaphornchai; Isaac Teitelbaum
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714

Review 10.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.